Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

Bohling SD, Davis E, Thompson K, Kussick SJ, Love J.

Cytometry B Clin Cytom. 2016 Nov;90(6):493-498. doi: 10.1002/cyto.b.21340. Epub 2015 Dec 22.

2.

comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays.

Bohling SD, Pagano MB, Stitzel MR, Ferrell C, Yeung W, Chandler WL.

Am J Clin Pathol. 2012 Feb;137(2):185-92. doi: 10.1309/AJCPGSJ4NHFQMX9W.

PMID:
22261442
3.

Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?

Jordan CD, Bohling SD, Charbonneau NL, Sakai LY.

J Histochem Cytochem. 2010 Oct;58(10):903-15. doi: 10.1369/jhc.2010.956615.

4.

Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.

Bohling SD, Allison KH.

Mod Pathol. 2008 Dec;21(12):1527-32. doi: 10.1038/modpathol.2008.160. Epub 2008 Sep 26.

5.

Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.

Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-Johnson KS, Lim MS.

Leuk Res. 2008 Mar;32(3):383-93. Epub 2007 Aug 27.

PMID:
17720243
6.

Validation of cDNA microarray gene expression data obtained from linearly amplified RNA.

Jenson SD, Robetorye RS, Bohling SD, Schumacher JA, Morgan JW, Lim MS, Elenitoba-Johnson KS.

Mol Pathol. 2003 Dec;56(6):307-12.

7.

BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissue.

Meda BA, Frost M, Newell J, Bohling SD, Huebner-Chan DR, Perkins SL, Lim MS, Medeiros LJ, Elenitoba-Johnson KS.

Am J Surg Pathol. 2003 Jul;27(7):888-94.

PMID:
12826880
8.

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z, Tripp S, Shami PJ, Wang LY, Coupland RW, Buckstein R, Perez-Ordonez B, Perkins SL, Dube ID, Lim MS.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7259-64. Epub 2003 May 19.

9.

Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Robetorye RS, Bohling SD, Morgan JW, Fillmore GC, Lim MS, Elenitoba-Johnson KS.

J Mol Diagn. 2002 Aug;4(3):123-36.

10.

Gene expression profiling of cell lines derived from T-cell malignancies.

Fillmore GC, Lin Z, Bohling SD, Robetorye RS, Kim CH, Jenson SD, Elenitoba-Johnson KS, Lim MS.

FEBS Lett. 2002 Jul 3;522(1-3):183-8.

11.

Fluorescence PCR quantification of cyclin D1 expression.

Elenitoba-Johnson KS, Bohling SD, Jenson SD, Lin Z, Monnin KA, Lim MS.

J Mol Diagn. 2002 May;4(2):90-6.

12.
13.

PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number.

Elenitoba-Johnson KS, Bohling SD, Mitchell RS, Brown MS, Robetorye RS.

J Mol Diagn. 2000 May;2(2):92-6.

14.

Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis.

Elenitoba-Johnson KS, Bohling SD, Wittwer CT, King TC.

Nat Med. 2001 Feb;7(2):249-53. No abstract available.

PMID:
11175859
15.
16.

Fluorescence melting curve analysis for the detection of the bcl-1/JH translocation in mantle cell lymphoma.

Bohling SD, Wittwer CT, King TC, Elenitoba-Johnson KS.

Lab Invest. 1999 Mar;79(3):337-45.

PMID:
10092070
17.

Supplemental Content

Loading ...
Support Center